| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/02/2002 | US6413744 Methods and host cells for improved cell culture |
| 07/02/2002 | US6413743 Amino acid sequence of protein which has greater inhibition of histamine controlled cyclic amp by thioperamide than by diphenhydramine or ranitidine; nervous system disorders |
| 07/02/2002 | US6413742 Culturing recombinant host cell having dna which codes for fibrillar collagen monomer lacking a c propeptide sequence selection and alignment domain, then producing fibrillar collagen |
| 07/02/2002 | US6413741 Nucleotide sequence; for potassium channel modulators and gene therapy |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413739 AMPA-binding human GLuR3 receptors |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413737 Ecarin prothrombin protease and methods |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413730 Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase |
| 07/02/2002 | US6413729 Peptidoglycan recognition proteins and their production |
| 07/02/2002 | US6413727 Detecting somatic alteration of wild-type protein in tumor tissue by immunoblotting; prognosis of cancer |
| 07/02/2002 | US6413723 High speed determination if nucleic acid is bound by binding factors; controlling gene expression |
| 07/02/2002 | US6413722 Silylation surface of solid support; activating with crosslinking agent; reacting with amine-containing polymer; attaching target polynucleotide |
| 07/02/2002 | US6413721 Methods of isolating common and specific antigens from excretory-secretory products of protostrongylidae |
| 07/02/2002 | US6413720 Method for the affinity isolation of newly synthesized RNA |
| 07/02/2002 | US6413719 KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| 07/02/2002 | US6413559 Baked goods |
| 07/02/2002 | US6413544 Sandwich liposome comprises biologically active agents internalized between two bilomellar liposomes; 1,2-bis(oleoyloxy)-3-(trimethylammonio)-propane chloride, cholesterol or cholesterol derivative |
| 07/02/2002 | US6413543 Phosphatidyl oligoglycerols |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413521 Helminth parasite antigen with aminopeptidase-like activity |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | US6413510 Dimeric modified groβ protein |
| 07/02/2002 | CA2283261C Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| 07/02/2002 | CA2253837C Therapeutic uses of bpi protein products for human meningococcemia |
| 07/02/2002 | CA2201714C Method for isolation of highly pure von willebrand factor |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2165839C Thermostable xylanase |
| 07/02/2002 | CA2159083C Recombinant .alpha.-n-acetylgalactosaminidase enzyme and cdna encoding said enzyme |
| 07/02/2002 | CA2133203C Hybrid human/porcine factor viii |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2080008C Water-soluble mutein of fibroblast growth factor (fgf) receptor |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 07/02/2002 | CA1341372C Hybrid dna synthesis of insulin |
| 06/27/2002 | WO2002050545A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 06/27/2002 | WO2002050542A1 Multiple-inspection multiplexing method and suspension for multiple-inspection multiplexing |
| 06/27/2002 | WO2002050540A1 Support for determining an analyte comprising a selective spectral filter |
| 06/27/2002 | WO2002050309A2 A bardet-biedl susceptibility gene and uses thereof |
| 06/27/2002 | WO2002050307A1 Method of detecting polymorphism in dna by using mass spectroscopy |
| 06/27/2002 | WO2002050305A1 Method for detecting whether an organism is homozygous or heterozygous using labelled primers and rflp |
| 06/27/2002 | WO2002050304A2 Oncolytic virus |
| 06/27/2002 | WO2002050302A2 Protein-protein interactions |
| 06/27/2002 | WO2002050295A2 Arcelin-5 promoter and uses thereof |
| 06/27/2002 | WO2002050294A1 A novel tissue specific plant promoter |
| 06/27/2002 | WO2002050293A2 Plants with improved resistance |
| 06/27/2002 | WO2002050292A2 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 06/27/2002 | WO2002050291A1 Hydrogen peroxide lyase regulatory region |
| 06/27/2002 | WO2002050290A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050288A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | WO2002050285A2 Histone deacetylase-related gene and protein |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | WO2002050282A1 Novel thermostable galactose isomerase and tagatose production thereby |
| 06/27/2002 | WO2002050281A1 Virus resistance in plants |
| 06/27/2002 | WO2002050280A2 Equine ige allotype |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050278A2 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2002050277A2 Protein and nucleic acids encoding same |
| 06/27/2002 | WO2002050276A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050275A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050274A2 Seleno-cysteine containing protein zsel1 |
| 06/27/2002 | WO2002050273A2 A transmembrane protein as a downstream target of neurotrophin and ephrin receptor tyrosine kinases, dna encoding same monoclonal antibodies thereto |
| 06/27/2002 | WO2002050272A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 06/27/2002 | WO2002050271A2 Human ion channel protein and polynucleotides encoding the same |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050268A1 Method of concentrating gene |
| 06/27/2002 | WO2002050264A2 Promoters and recombinant expression constructs |
| 06/27/2002 | WO2002050260A2 Process for the production and purification of secreted proteins ans the production of arrays of proteins |
| 06/27/2002 | WO2002050259A2 Compositions, methods and kits for identifying protein-protein interaction disrupting agents |
| 06/27/2002 | WO2002050258A1 Novel aggrecanase |
| 06/27/2002 | WO2002050257A2 Method for the production of polyfructans |
| 06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | WO2002050252A2 Method for generating competent or transformed cells |
| 06/27/2002 | WO2002050248A2 Antisense modulation of hepsin expression |
| 06/27/2002 | WO2002050247A2 Antisense modulation of hepsin expression |
| 06/27/2002 | WO2002050245A2 Novel cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 06/27/2002 | WO2002050244A2 Antisense modulation of histone deacetylase 1 expression |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050118A2 Single-strand antibody with improved stability |
| 06/27/2002 | WO2002050117A2 G-proteins coupled receptor proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050113A2 Interleukin-1 related gene and protein |
| 06/27/2002 | WO2002050110A1 Novel gene encoding an f-box protein which regulates leaf longevity in arabidopsis thaliana and mutant gene thereof |
| 06/27/2002 | WO2002050109A2 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |